The Petri Dish: FDA rejects Biogen drug, a new Covid-19 antibody heads to Phase 3

Here’s the latest weekly biotech news roundup from Rowan Walrath, The Petri Dish, where you can read about FDA rejections, oncology startups, new science execs and clinical trials.